• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Athenahealth Launches COVID-19 Dashboards Tracking Lab Test Orders & High-Risk Patients

Share:

April 7, 2020

Highlights on this story:
  • athenahealth launches two real-time COVID-19 dashboards for the healthcare community that enable users to track and predict which hospitals may need more support based on the number of tests being performed and the number of people at risk of developing severe illness from COVID-19.
  • athenahealth’s COVID-19 high-risk populations dashboard identifies concentrated areas of high-risk patients, enabling local hospitals and clinicians to prepare for the potential case volume, which will help improve the delivery of COVID-19 related care.
  • athena’s COVID-19 lab test dashboard shows the number of lab tests ordered over time by clinicians nationwide and provides insight into where across the country testing capabilities are growing the fastest.

athenahealth, Inc., a provider of network-enabled software and services for ambulatory and enterprise customers nationwide has released two new interactive COVID-19 dashboards track lab test orders and identify concentrations of high-risk patients, via data from its providers across 50 states and 100 million patients

The data will be used by the COVID-19 Healthcare Coalition and athenahealth’s customers to augment current information on testing and inform decisions on healthcare delivery systems and people at risk of severe illness from COVID-19 who need diagnostic testing.

Interactive COVID-19 Dashboards

As part of the initiative, athenahealth is launching two interactive COVID-19 dashboards that will also inform the healthcare community and the public at large. They are:

Clinician-Ordered Lab Tests Dashboard

Leveraging athenahealth’s open and connected network, the athenahealth COVID-19 lab test dashboard provides a visual representation via an interactive map that shows the number of lab tests ordered over time by clinicians using the athenahealth network nationwide. It allows viewers to look at the data locally by state and across the nation. The dashboard is updated on a regular basis to show near real-time trends in test orders. For example, lab tests on the athenahealth network increased almost 8X between the weeks of March 9 and March 24. While the absolute numbers of lab tests ordered by athenahealth customers are a portion of the total number of actual lab tests performed across the country, the data provides insight into where testing capabilities are growing the fastest.

High-Risk Patients Dashboard

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

The athenahealth COVID-19 high-risk populations dashboard utilizes data from athenahealth providers to detect concentrations of patients on a county-by-county basis that are over 65 years of age and/or have one or more of the CDC-defined co-morbidities that put them at a high risk of serious illness if they acquire COVID-19. The map shows relative hot spots of these high-risk patients throughout the U.S. and allows viewers to look at how much of the population is over 65 years of age has relevant health conditions, or both risk factors together. These insights will enable the healthcare community to see which states and counties have the most high-risk patients and allow them to prepare for the potential case volume in specific areas.

“As COVID-19 cases continue to grow across the country, it is critically important that our nation’s leaders have current information to inform decisions on where to deploy hospital resources and bolster clinical infrastructure,” said Bob Segert, Chairman and CEO of athenahealth. “Our COVID-19 dashboards enable users to track and predict which area hospitals may need more support based on the number of tests being performed and the number of people at risk of developing severe illness from COVID-19. By providing this data from our connected network, we aim to help providers on the frontlines battling the coronavirus and potentially slow the number of fatalities from this pandemic.”

COVID-19 Dashboard Methodology

Using de-identified EHR data at the state and national level, the COVID-19 lab tests dashboard reports on COVID-19 lab tests ordered by clinicians around the country through the athenaClinicals EHR. The COVID-19 high-risk populations’ dashboard leverages deidentified data from patients who have seen an athenahealth primary care provider within the last three years and notes whether they have risk factors based on information from the CDC, including age and comorbidities, for severe illness with COVID-19.

The data is analyzed by athenahealth’s Research and Insights team, led by Jessica Sweeney-Platt, Executive Director, which is comprised of healthcare researchers and data scientists on a mission to help athenahealth’s customers and to use its unique data asset to improve the healthcare system with data-backed insights. The team tackles some of the biggest challenges in healthcare, from provider burnout to patient engagement, using a variety of statistical techniques combined with surveys, observations, and interviews.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • UCLA Spin Out DEARhealth Lands $6M for AI-Powered Pathways for Power CareUCLA Spin Out DEARhealth Lands $6M for AI-Powered Pathways for Power Care
  • Does Warm Weather Slow the Spread of the Virus – Maybe?Does Warm Weather Slow the Spread of the Virus – Maybe?
  • Global Pharmaceutical Contract Development and Manufacturing Organization (CMO) Market Report 2021-2030: API Manufacturing, FDF Development and Manufacturing, & Secondary PackagingGlobal Pharmaceutical Contract Development and Manufacturing Organization (CMO) Market Report 2021-2030: API Manufacturing, FDF Development and Manufacturing, & Secondary Packaging
  • Global COVID-19 Treatment Industry Top-Vendor And Industry Insights By End-User Segments Till 2027Global COVID-19 Treatment Industry Top-Vendor And Industry Insights By End-User Segments Till 2027
  • Dassault Systèmes Completes Acquisition of Medidata Opening Up a New World of Virtual Twin Experiences for HealthcareDassault Systèmes Completes Acquisition of Medidata Opening Up a New World of Virtual Twin Experiences for Healthcare
  • Analysis: August Health IT M&A Activity; Public Company PerformanceAnalysis: August Health IT M&A Activity; Public Company Performance
  • Quest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology LaboratoriesQuest Diagnostics Completes Acquisition of Laboratory Services Business of Boyce & Bynum Pathology Laboratories
  • Q Bio Raises $40 Million Series B Led By Andreessen Horowitz to Bring Preventative Health and the Physical of the Future to MassesQ Bio Raises $40 Million Series B Led By Andreessen Horowitz to Bring Preventative Health and the Physical of the Future to Masses

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications